Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Translational Research Faces Cultural, Not Just Scientific, Barriers To Success; Industry, Academia, Govt. Meet At NIH To Talk Collaboration

Executive Summary

NIH's translational research consortium may have to transcend fundamental "cultural differences" that have dogged industry/academia collaborations for decades in order to usher in the new era of public/private collaboration envisioned when the Clinical and Translational Sciences Awards program was created four years ago

You may also be interested in...



Academia May Find That Earlier Industry Partnering Entails Demands For Longer-Term Data Development, Woodcock Cautions

At NIH meeting on academic/industry partnerships, Woodcock also urges academic institutions to maintain commitments to developing enabling technologies.

NIH Translational Research Consortium Mulls How Best To Leverage Agency's Stake In Industry, Academia, Government Relationships

"We all have different carrots and different challenges, but we also have a great deal in common, including the goal to provide improved treatments and preventions for the public," says NCRR Director Alving.

Conflicts of Interest By Academics Should Be Better Policed By NIH, OIG Says

The National Institutes of Health is being pressured to play a greater role in eliminating financial conflicts of interest among academic researchers

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051955

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel